The University Hospital of Montpellier is the oldest medical faculty in Europe, part of the University of Montpellier. It has been rated the 6th best hospital in France.

During the past decade, CHU Montpellier conducted 607 clinical trials. In the 10-year time frame, 607 clinical trials started and 29 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 299 clinical trials started and 19 clinical trials were completed. i.e. 6.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Montpellier" #1 sponsor was "University Hospital, Montpellier" with 290 trials, followed by "Centre Hospitalier Universitaire de Nīmes" with 33 trials sponsored, "Nantes University Hospital" with 30 trials sponsored, "University Hospital, Toulouse" with 23 trials sponsored and "University Hospital, Bordeaux" with 23 trials sponsored. Other sponsors include 381 different institutions and companies that sponsored additional 161 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Montpellier" #1 collaborator was "Ministry of Health, France" with 28 trials as a collaborator, "University Hospital, Montpellier" with 15 trials as a collaborator, "Centre Hospitalier Universitaire de Nīmes" with 7 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 7 trials as a collaborator and "University Hospital, Lille" with 7 trials as a collaborator. Other collaborators include 520 different institutions and companies that were collaborators in the rest 414 trials.

According to Clinical.Site data, the most researched conditions in "CHU Montpellier" are "Rheumatoid Arthritis" (14 trials), "Heart Failure" (12 trials), "Multiple Sclerosis" (12 trials), "Depression" (10 trials) and "Stroke" (9 trials). Many other conditions were trialed in "CHU Montpellier" in a lesser frequency.

Most popular intervention types in "CHU Montpellier" are "Other" (240 trials), "Drug" (203 trials), "Device" (117 trials), "Procedure" (87 trials) and "Behavioral" (45 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Blood sample" (9 trials), "Rituximab" (7 trials), "blood sample" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "CHU Montpellier" are 721 trials for "All" genders, 51 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 281 active trials in "CHU Montpellier". 26 are not yet recruiting, 212 are recruiting, 41 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 323 completed trials in CHU Montpellier, 2 suspended trials, and 82 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Montpellier, 10 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 349 trials that are defined as “Not Applicable".

CHU Montpellier has several departments that took part in Clinical trials: "Hopital Gui de Chauliac; Neurologie" - 15 trials, "Hôpital Saint-Eloi - Hématologie Clinique" - 14 trials, "Hopital Saint Eloi; CHU de Montpellier; Svc de Dermatologie" - 5 trials, "CHU Montpellier, Nephrology department" - 5 trials, "Hopital Lapeyronie; Immunologie Rhumatologie" - 4 trials, "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" - 4 trials, "Centre d'Investigation Clinique" - 3 trials, "CHU Montpellier - Hôpital St Eloi - Service Maladies Vasculaires" - 2 trials, "Service d'Hépaogastroentérologie - Hôpital Saint Eloi" - 2 trials, "Virologie" - 2 trials